82 related articles for article (PubMed ID: 10565039)
1. Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo.
Wang H; Lu D; Reaves PY; Katovich MJ; Raizada MK
Methods Enzymol; 2000; 314():581-90. PubMed ID: 10565039
[TBL] [Abstract][Full Text] [Related]
2. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.
Martens JR; Reaves PY; Lu D; Katovich MJ; Berecek KH; Bishop SP; Raizada MK; Gelband CH
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2664-9. PubMed ID: 9482944
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.
Reaves PY; Wang HW; Katovich MJ; Gelband CH; Raizada MK
Methods; 2000 Nov; 22(3):211-8. PubMed ID: 11071816
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of ANG II actions by adenovirus delivery of AT1 receptor antisense in neurons and SMC.
Lu D; Yang H; Raizada MK
Am J Physiol; 1998 Feb; 274(2):H719-27. PubMed ID: 9486279
[TBL] [Abstract][Full Text] [Related]
5. Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain.
Lu D; Raizada MK
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2914-8. PubMed ID: 7708748
[TBL] [Abstract][Full Text] [Related]
6. Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring.
Reaves PY; Gelband CH; Wang H; Yang H; Lu D; Berecek KH; Katovich MJ; Raizada MK
Circ Res; 1999 Nov; 85(10):e44-50. PubMed ID: 10559146
[TBL] [Abstract][Full Text] [Related]
7. Delivery of antisense DNA by vectors for prolonged effects in vitro and in vivo.
Mohuczy D; Tang X; Phillips MI
Methods Enzymol; 2000; 314():32-51. PubMed ID: 10565003
[No Abstract] [Full Text] [Related]
8. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
Iyer SN; Lu D; Katovich MJ; Raizada MK
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9960-5. PubMed ID: 8790439
[TBL] [Abstract][Full Text] [Related]
9. The future of hypertension therapy: sense, antisense, or nonsense?
Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK
Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300
[TBL] [Abstract][Full Text] [Related]
10. Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule.
Cheng HF; Wang JL; Vinson GP; Harris RC
Am J Physiol; 1998 Jan; 274(1):F10-7. PubMed ID: 9458818
[TBL] [Abstract][Full Text] [Related]
11. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
[TBL] [Abstract][Full Text] [Related]
12. Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA.
Wang H; Katovich MJ; Gelband CH; Reaves PY; Phillips MI; Raizada MK
Circ Res; 1999 Oct; 85(7):614-22. PubMed ID: 10506486
[TBL] [Abstract][Full Text] [Related]
13. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR.
Katovich MJ; Gelband CH; Reaves P; Wang HW; Raizada MK
Am J Physiol; 1999 Sep; 277(3):H1260-4. PubMed ID: 10484448
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
Pachori AS; Numan MT; Ferrario CM; Diz DM; Raizada MK; Katovich MJ
Hypertension; 2002 May; 39(5):969-75. PubMed ID: 12019278
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with amlodipine modulates adrenocortical angiotensin II receptors in spontaneously hypertensive rats.
Kishida M; Otsuka F; Ogura T; Kataoka H; Nakamura Y; Yamauchi T; Takahashi M; Yokota K; Mimura Y; Makino H
Life Sci; 2001 May; 69(1):113-22. PubMed ID: 11411801
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for hypertension: sense and antisense strategies.
Phillips MI
Expert Opin Biol Ther; 2001 Jul; 1(4):655-62. PubMed ID: 11727501
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy to control hypertension: current studies and future perspectives.
Sellers KW; Katovich MJ; Gelband CH; Raizada MK
Am J Med Sci; 2001 Jul; 322(1):1-6. PubMed ID: 11465240
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of partial phosphorothioated AT1 receptor antisense oligonucleotides in spontaneously hypertensive and normotensive rats.
Piegari E; Galderisi U; Berrino L; Di Bernardo G; Cipollaro M; Esposito F; Rossi F; Cascino A
Life Sci; 2000 Apr; 66(21):2091-9. PubMed ID: 10823348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
